Balance Sheet - NewAmsterdam Pharma Co N.V. (NAMS)
$(Billion, Million)| Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | |
|---|---|---|---|---|---|---|
| Total cash and short-term investments | 636.24 | 834.19 | 340.45 | 467.73 | 60.38 | 1.37 |
| Accounts receivable, net | 23.15 | 21.31 | 1.88 | 2.07 | 4.86 | |
| Inventories | -1.71 | 0.02 | 0.00 | |||
| Other current assets | 16.31 | 7.92 | 4.46 | 10.25 | 6.58 | 0.50 |
| Total current assets | 675.70 | 863.41 | 346.79 | 477.98 | 66.96 | 1.87 |
| Total non-current assets | 93.58 | 1.21 | 0.31 | 0.52 | 1.03 | 138.00 |
| Total assets | 769.28 | 864.62 | 347.10 | 478.50 | 67.99 | 139.87 |
| Total current liabilities | 85.79 | 106.92 | 49.90 | 36.06 | 11.24 | 0.24 |
| Total non-current liabilities | 0.07 | 0.20 | 8.81 | 12.37 | 0.13 | 12.17 |
| Total liabilities | 85.85 | 107.12 | 58.70 | 48.43 | 11.36 | 12.41 |
| Total stockholders' equity | 683.43 | 757.50 | 288.39 | 430.07 | 56.63 | 127.46 |
| Common shares outstanding | 114 | 94 | 82 | 19 | 18 | 18 |
Show Quarterly Balance Sheet
Balance Sheet - NewAmsterdam Pharma Co N.V. (NAMS)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Mar-23 | Dec-22 | Sep-22 | Jun-22 | Mar-22 | Dec-21 | Sep-21 | Jun-21 | Mar-21 | Dec-20 | Sep-20 | Jun-20 | Mar-20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total cash and short-term investments | 636.11 | 636.24 | 702.95 | 739.16 | 808.48 | 834.19 | 422.73 | 430.71 | 481.15 | 340.45 | 0.00 | 418.66 | 1.97 | 467.73 | 467.73 | 93.74 | 0.71 | 60.38 | 0.64 | 0.79 | 1.16 | 1.37 | 1.97 | 1.97 | 1.97 |
| Accounts receivable, net | 8.22 | 23.15 | 20.25 | 19.75 | 1.61 | 21.31 | 5.15 | 5.04 | 4.13 | 1.88 | 5.77 | 1.07 | 1.94 | 120.48 | 115.61 | 4.86 | 1.07 | 1.07 | 1.07 | ||||||
| Inventories | -5.15 | -5.04 | 0.00 | -1.71 | -1.94 | -1.07 | -1.07 | -1.07 | |||||||||||||||||
| Other current assets | 13.72 | 16.31 | 9.13 | 30.69 | 7.21 | 7.92 | 10.00 | 14.64 | 6.68 | 6.34 | 6.30 | 0.34 | 10.25 | 10.25 | 13.07 | 0.22 | 6.58 | 0.33 | 0.42 | 0.48 | 0.50 | 0.34 | 0.34 | 0.34 | |
| Total current assets | 658.04 | 675.70 | 732.33 | 769.85 | 817.30 | 863.41 | 437.87 | 445.35 | 487.82 | 346.79 | 424.96 | 2.30 | 477.98 | 477.98 | 227.29 | 0.93 | 66.96 | 0.97 | 1.21 | 1.64 | 1.87 | 2.30 | 2.30 | 2.30 | |
| Total non-current assets | 74.60 | 93.58 | 54.10 | 45.26 | 1.11 | 1.21 | 1.32 | 1.34 | 0.64 | 0.31 | 89.34 | 0.00 | 0.52 | 0.52 | 0.95 | 124.74 | 1.03 | 138.01 | 138.01 | 138.01 | 138.00 | 0.00 | 0.00 | 0.00 | |
| Total assets | 732.64 | 769.28 | 786.43 | 815.11 | 818.41 | 864.62 | 439.19 | 446.69 | 488.46 | 347.10 | 514.30 | 2.31 | 478.50 | 478.50 | 228.24 | 125.67 | 67.99 | 138.98 | 139.22 | 139.64 | 139.87 | 2.31 | 2.31 | 2.31 | |
| Total current liabilities | 67.42 | 85.79 | 58.27 | 36.51 | 40.91 | 106.92 | 41.26 | 45.31 | 59.73 | 49.90 | 41.85 | 3.20 | 36.06 | 36.06 | 27.14 | 0.10 | 11.24 | 0.25 | 0.12 | 0.24 | 0.24 | 3.20 | 3.20 | 3.20 | |
| Total non-current liabilities | 0.00 | 0.07 | 0.09 | 0.10 | 0.14 | 0.20 | 19.07 | 13.94 | 16.93 | 8.81 | 11.46 | 0.03 | 12.37 | 12.37 | 7.89 | 5.36 | 0.13 | 8.02 | 10.12 | 9.12 | 12.17 | ||||
| Total liabilities | 67.42 | 85.85 | 58.36 | 36.62 | 41.05 | 107.12 | 60.33 | 59.25 | 76.66 | 58.70 | 53.31 | 3.20 | 48.43 | 48.43 | 35.03 | 5.45 | 11.36 | 8.27 | 10.24 | 9.36 | 12.41 | 3.20 | 3.20 | 3.20 | |
| Total stockholders' equity | 665.22 | 683.43 | 728.07 | 778.50 | 777.36 | 757.50 | 378.86 | 387.44 | 411.80 | 288.39 | 460.99 | -0.89 | 430.07 | 430.07 | 193.21 | 120.22 | 56.63 | 130.71 | 128.98 | 130.28 | 127.46 | -0.89 | -0.89 | -0.89 | |
| Common shares outstanding | 121 | 114 | 119 | 113 | 116 | 97 | 95 | 95 | 82 | 82 | 82 | 82 | 82 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 86 | 86 | 86 |